CPAP provides immediate control of sleep apnea symptoms, while GLP-1 medications may help reduce the long-term severity of the condition through sustained weight loss
This isnt because GLP1 medications are inherently dangerous for these patients but because the rapid changes in appetite, body weight, and eating patterns can interact with existing vulnerabilities
NAC supplies a precursor and depends on the bodys synthesis pathway
Stacking peptides allows you to support the biology more broadly while avoiding the need to overdrive one pathway
In respect to their cardiovascular effects among patients with T2DM, both GLP-1RAs and SGLT2is have been shown to reduce the risk of MACE (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke), with GLP-1RAs reducing the risk of non-fatal stroke to a greater extent [3, 6]